You can buy or sell Tricida and other stocks, options, ETFs, and crypto commission-free!
Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Read More The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Expected Nov 7, After Hours